|
|
|
|
|
by travmatt
1852 days ago
|
|
If a company is aware that a new drug could cure a previously managed disease, it’s pretty obvious that you’d like to be the one pocketing any available profits before a competitor does. The conspiracy only works to the extent that nobody else in the world could create the same drug, and that every person aware of its existence is prepared to keep it secret and lose out on the money to be made selling it. |
|
Could create it and make a profit selling it.
If the cure generates less profit than current treatment, and if you’re currently selling treatment, then that’s not going to be worth it for you.
If you don’t, well you still need to get it to market, which requires substantial investment.
My point is that the described scenario is not entirely unlikely. For example, type 1 diabetics in the US need something like $600 worth of insulin, every single month for the rest of their lives. Say that’s 60 years, you’re looking at $430k, not even counting needles, sensors, and other stuff they might need (or absolutely need). Average patients won’t be able to cough up nearly as much for a cure.
Pharma has just been way faster than tech in realizing that the subscription model has far better yields.